search
Back to results

Coronariography in OUt of hosPital Cardiac arrEst (COUPE)

Primary Purpose

Cardiac Arrest

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Urgent Coronary Angiography
Deferred Coronary Angiography
Sponsored by
Hospital San Carlos, Madrid
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Arrest focused on measuring cardiac arrest, survival, neurologic prognosis, coronariography, hypothermia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: survivors from out of hospital cardiac arrest who meet all the following criteria:

  • Remain comatose after recovery of spontaneous circulation (ROSC) (Glasgow Coma Scale score equal or less than 8).
  • Show a non-diagnostic electrocardiogram after ROSC (neither ST segment elevation nor left bundle branch block).
  • Prior rule out of an obvious non-cardiac cause of the cardiac arrest (head CT scan and transthoracic echocardiogram).
  • Absence of exclusion criteria.

Exclusion Criteria:

  • Age <18 years.
  • Pregnant women or women of childbearing age unless they have a negative pregnancy test.
  • Time to return of spontaneous circulation longer than 60 minutes.
  • Non-cardiac etiology of the comatose state: drug overdose, head injury or stroke.
  • Acute myocardial infarction with ST segment elevation or left bundle branch block, because in those patients emergent angiography is mandatory.
  • Hemodynamic instability (refractory cardiogenic shock despite vasoactive drugs or refractory arrhythmias), because in those patients an emergent angiography is mandatory.
  • Known coagulopathy or bleeding.
  • Refusal to participate in the study by the next of kin.

Sites / Locations

  • Hospital Clínico San Carlos

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Urgent Coronary Angiography

Deferred coronariography

Arm Description

Urgent Coronary Angiography: as soon as possible, when the patient is randomized.

Deferred coronary angiography: after extubation if the patient has a good neurologic prognosis.

Outcomes

Primary Outcome Measures

Survival with good neurological outcome for activities of daily living (CPC 1-2).
Survival with good neurological outcome for activities of daily living (CPC 1-2).
Survival with good neurological outcome for activities of daily living (CPC 1-2).
Survival with good neurological outcome for activities of daily living (CPC 1-2).
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.

Secondary Outcome Measures

Hospital survival.
Hospital survival.
Hospital survival.
Hospital survival.
Neurological outcome assessed by the Cerebral Performance Category (CPC) Scale.
Neurological outcome assessed by the Cerebral Performance Category (CPC)
Neurological outcome assessed by the Cerebral Performance Category (CPC) Scale.
Neurological outcome assessed by the Cerebral Performance Category (CPC)
Left ventricular ejection fraction.
Left ventricular ejection fraction.
Left ventricular ejection fraction.
Left ventricular ejection fraction.
Infarction size
Defined by the maximum CPK (creatine phosphokinase) and Troponin.
Vascular complications.
Vascular complications such as pseudoaneurysms, arteriovenous fistulas, etc
Clinically evident haemorrhagia: BARC> 2
Clinically evident haemorrhagia: BARC> 2
Sustained ventricular arrythmias or requirement of cardioversion.
Sustained ventricular arrythmias or requirement of cardioversion.
Renal impairment.
A 50% increase of serum creatinine over a baseline level or an increase of >0.5 mg/dl
Reinfarction.
According to the Universal Definition of Acute Myocardial Infarction
Stent Thrombosis
Defined by the Academic Research Consortium (ARC).
Infections.
Infections.
Length of intubation.
Length of intubation.
Length of hospital stay.
Length of hospital stay.

Full Information

First Posted
December 20, 2015
Last Updated
August 24, 2021
Sponsor
Hospital San Carlos, Madrid
Collaborators
Hospital Clínico Universitario de Valladolid, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Hospital Vall d'Hebron, Hospital Arnau de Vilanova, Hospital Universitari de Bellvitge, Hospital General Universitario Gregorio Marañon, Institut d Investigación Biomedica Dr. Josep Trueta de Girona, Hospital Universitario Ramon y Cajal, Hospital Clinic of Barcelona, Hospital Universitario Virgen Macarena, Hospital Universitario de Canarias, Germans Trias i Pujol Hospital, Complejo Hospitalario Universitario de Santiago, Hospital Universitario Principe de Asturias, Hospital Universitari Joan XXIII de Tarragona., Hospital de Leon
search

1. Study Identification

Unique Protocol Identification Number
NCT02641626
Brief Title
Coronariography in OUt of hosPital Cardiac arrEst
Acronym
COUPE
Official Title
Randomized Study About the Efficacy of an Urgent Coronariography in Patients With a Non-diagnostic Electrocardiogram Following Out of Hospital Cardiac Arrest.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
January 2016 (Actual)
Primary Completion Date
January 31, 2021 (Actual)
Study Completion Date
January 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital San Carlos, Madrid
Collaborators
Hospital Clínico Universitario de Valladolid, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Hospital Vall d'Hebron, Hospital Arnau de Vilanova, Hospital Universitari de Bellvitge, Hospital General Universitario Gregorio Marañon, Institut d Investigación Biomedica Dr. Josep Trueta de Girona, Hospital Universitario Ramon y Cajal, Hospital Clinic of Barcelona, Hospital Universitario Virgen Macarena, Hospital Universitario de Canarias, Germans Trias i Pujol Hospital, Complejo Hospitalario Universitario de Santiago, Hospital Universitario Principe de Asturias, Hospital Universitari Joan XXIII de Tarragona., Hospital de Leon

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Prospective, multicenter, randomized clinical trial. Survivors from an out-of-hospital cardiac arrest (OHCA) without ST segment elevation in their EKG will be recruited. Potentially non-cardiac etiology of the cardiac arrest will be ruled out prior to randomization. Primary goal (treatment): to evaluate the efficacy of urgent vs deferred coronary angiography in survivors from OHCA without ST-segment elevation in the EKG.
Detailed Description
Prospective, multicenter and randomized clinical trial. Survivors from Out-of-Hospital Cardiac Arrest (OHCA) who do not show ST elevation in their EKG will be recruited in the present study. Potentially non-cardiac ethiology of the cardiac arrest will be ruled out prior to randomization. Afterwards, patients will be randomized to emergent or deferred (performed before discharge) coronary angiography. Both groups will receive routine care in the Acute Cardiac Care Unit, including therapeutic hypothermia. The randomization will be in a 1:1 ratio to urgent or deferred coronary angiography. The main objective of the study is to compare the effectiveness of an urgent coronary angiography and angioplasty if necessary versus a deferred coronary angiography in survivors from OHCA who after recovery of spontaneous circulation do not fulfill criteria for ST-elevation myocardial infarction. The primary efficacy endpoint is a composite of in-hospital survival and six-month survival free of severe dependence, which will be evaluated by using the Cerebral Performance Category (CPC) Scale, being good prognosis represented by the categories 1 and 2.The safety endpoint will be a composite of MACE (Major Adverse Cardiac Events) including: death, reinfarction, bleeding or ventricular arrhythmias. A total of 166 patients will be included. The estimated duration will be 42 months, with a target follow-up of 6 months. Periods will be divided as follows: Inclusion Period (selection of the population and data collection): 36 months. Monitoring, data analysis, statistical and clinical report: 6 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest
Keywords
cardiac arrest, survival, neurologic prognosis, coronariography, hypothermia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
72 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Urgent Coronary Angiography
Arm Type
Experimental
Arm Description
Urgent Coronary Angiography: as soon as possible, when the patient is randomized.
Arm Title
Deferred coronariography
Arm Type
Active Comparator
Arm Description
Deferred coronary angiography: after extubation if the patient has a good neurologic prognosis.
Intervention Type
Procedure
Intervention Name(s)
Urgent Coronary Angiography
Intervention Description
Diagnostic test for the evaluation of the coronary vasculature.
Intervention Type
Procedure
Intervention Name(s)
Deferred Coronary Angiography
Intervention Description
Diagnostic test for the evaluation of the coronary vasculature.
Primary Outcome Measure Information:
Title
Survival with good neurological outcome for activities of daily living (CPC 1-2).
Description
Survival with good neurological outcome for activities of daily living (CPC 1-2).
Time Frame
30 days.
Title
Survival with good neurological outcome for activities of daily living (CPC 1-2).
Description
Survival with good neurological outcome for activities of daily living (CPC 1-2).
Time Frame
6 months.
Title
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.
Description
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.
Time Frame
30 days.
Title
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.
Description
MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias.
Time Frame
6 months.
Secondary Outcome Measure Information:
Title
Hospital survival.
Description
Hospital survival.
Time Frame
30 days.
Title
Hospital survival.
Description
Hospital survival.
Time Frame
6 months.
Title
Neurological outcome assessed by the Cerebral Performance Category (CPC) Scale.
Description
Neurological outcome assessed by the Cerebral Performance Category (CPC)
Time Frame
30 days.
Title
Neurological outcome assessed by the Cerebral Performance Category (CPC) Scale.
Description
Neurological outcome assessed by the Cerebral Performance Category (CPC)
Time Frame
6 months.
Title
Left ventricular ejection fraction.
Description
Left ventricular ejection fraction.
Time Frame
30 days.
Title
Left ventricular ejection fraction.
Description
Left ventricular ejection fraction.
Time Frame
6 months.
Title
Infarction size
Description
Defined by the maximum CPK (creatine phosphokinase) and Troponin.
Time Frame
30 days.
Title
Vascular complications.
Description
Vascular complications such as pseudoaneurysms, arteriovenous fistulas, etc
Time Frame
30 days.
Title
Clinically evident haemorrhagia: BARC> 2
Description
Clinically evident haemorrhagia: BARC> 2
Time Frame
30 days.
Title
Sustained ventricular arrythmias or requirement of cardioversion.
Description
Sustained ventricular arrythmias or requirement of cardioversion.
Time Frame
30 days.
Title
Renal impairment.
Description
A 50% increase of serum creatinine over a baseline level or an increase of >0.5 mg/dl
Time Frame
30 days.
Title
Reinfarction.
Description
According to the Universal Definition of Acute Myocardial Infarction
Time Frame
30 days.
Title
Stent Thrombosis
Description
Defined by the Academic Research Consortium (ARC).
Time Frame
30 days.
Title
Infections.
Description
Infections.
Time Frame
30 days.
Title
Length of intubation.
Description
Length of intubation.
Time Frame
30 days.
Title
Length of hospital stay.
Description
Length of hospital stay.
Time Frame
6 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: survivors from out of hospital cardiac arrest who meet all the following criteria: Remain comatose after recovery of spontaneous circulation (ROSC) (Glasgow Coma Scale score equal or less than 8). Show a non-diagnostic electrocardiogram after ROSC (neither ST segment elevation nor left bundle branch block). Prior rule out of an obvious non-cardiac cause of the cardiac arrest (head CT scan and transthoracic echocardiogram). Absence of exclusion criteria. Exclusion Criteria: Age <18 years. Pregnant women or women of childbearing age unless they have a negative pregnancy test. Time to return of spontaneous circulation longer than 60 minutes. Non-cardiac etiology of the comatose state: drug overdose, head injury or stroke. Acute myocardial infarction with ST segment elevation or left bundle branch block, because in those patients emergent angiography is mandatory. Hemodynamic instability (refractory cardiogenic shock despite vasoactive drugs or refractory arrhythmias), because in those patients an emergent angiography is mandatory. Known coagulopathy or bleeding. Refusal to participate in the study by the next of kin.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ana Viana Tejedor, MD, PhD
Organizational Affiliation
Hospital Clinico San Carlos
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Clínico San Carlos
City
Madrid
ZIP/Postal Code
28040
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
25195073
Citation
Camuglia AC, Randhawa VK, Lavi S, Walters DL. Cardiac catheterization is associated with superior outcomes for survivors of out of hospital cardiac arrest: review and meta-analysis. Resuscitation. 2014 Nov;85(11):1533-40. doi: 10.1016/j.resuscitation.2014.08.025. Epub 2014 Sep 4.
Results Reference
result
PubMed Identifier
23479672
Citation
Morrison LJ, Neumar RW, Zimmerman JL, Link MS, Newby LK, McMullan PW Jr, Hoek TV, Halverson CC, Doering L, Peberdy MA, Edelson DP; American Heart Association Emergency Cardiovascular Care Committee, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on P. Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association. Circulation. 2013 Apr 9;127(14):1538-63. doi: 10.1161/CIR.0b013e31828b2770. Epub 2013 Mar 11. No abstract available.
Results Reference
result
PubMed Identifier
35750580
Citation
Viana-Tejedor A, Andrea-Riba R, Scardino C, Ariza-Sole A, Baneras J, Garcia-Garcia C, Jimenez Mena M, Vila M, Martinez-Selles M, Pastor G, Garcia Acuna JM, Loma-Osorio P, Garcia Rubira JC, Jorge Perez P, Pastor P, Ferrera C, Noriega FJ, Perez Macias N, Fernandez-Ortiz A, Perez-Villacastin J; COUPE Investigators. Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial. Rev Esp Cardiol (Engl Ed). 2023 Feb;76(2):94-102. doi: 10.1016/j.rec.2022.05.013. Epub 2022 Jun 22. English, Spanish.
Results Reference
derived

Learn more about this trial

Coronariography in OUt of hosPital Cardiac arrEst

We'll reach out to this number within 24 hrs